14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
SMCI vs ZEPP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Super Micro Computer, Inc. (SMCI) captures the overall head-to-head institutional edge over Zepp Health Corporation (ZEPP) on higher Unified Composite conviction (43.2/100 HOLD vs. 45.7/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Profitability & Quality), while ZEPP wins 4–2 across the 6-pillar growth and valuation breakdown. SMCI trades at $21.65 (4.5x Forward P/E, 8.3% operating margin) versus ZEPP at $2.31 (3.1x Forward P/E, -12.6% operating margin).
Composite vs. Pillar Nuance: While ZEPP currently prints a higher short-term Unified Composite Score (45.7/100 HOLD vs. SMCI 43.2/100 HOLD), SMCI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (8.3% vs. -12.6% operating margin) and revenue trajectory (+297.5% vs. +6.9% YoY).
Technical & Structure Timing Caution: SMCI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 27.8); meanwhile ZEPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SMCI vs ZEPP. Trailing 12-month operating profitability (SMCI 8.3% vs ZEPP -12.6%) and valuation multiples (SMCI 4.5x vs ZEPP 3.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Consumer Electronics value chain with $37.0M market capitalization and -12.6% operating margin.
OpEx & R&D Reinvestment51.2% of Rev ($141M)
90D Engineering Disclosures0 Published
Investor FAQ SMCI vs ZEPP Key Questions & Quantitative Answers
As of Nov 20, 2026, Super Micro Computer, Inc. (SMCI) captures the overall head-to-head institutional edge over Zepp Health Corporation (ZEPP) on higher Unified Composite conviction (43.2/100 HOLD vs. 45.7/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Profitability & Quality), while ZEPP wins 4–2 across the 6-pillar growth and valuation breakdown. SMCI trades at $21.65 (4.5x Forward P/E, 8.3% operating margin) versus ZEPP at $2.31 (3.1x Forward P/E, -12.6% operating margin). Composite vs. Pillar Nuance: While ZEPP currently prints a higher short-term Unified Composite Score (45.7/100 HOLD vs. SMCI 43.2/100 HOLD), SMCI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (8.3% vs. -12.6% operating margin) and revenue trajectory (+297.5% vs. +6.9% YoY). Technical & Structure Timing Caution: SMCI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 27.8); meanwhile ZEPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SMCI leads the Growth & Scale pillar: SMCI posts +297.5% YoY revenue growth and +581.3% YoY earnings growth on $54.0B TTM revenue (11.4% gross margin, 8.3% operating margin), compared with ZEPP at +6.9% YoY revenue growth and -68.1% YoY earnings growth on $276M TTM revenue (38.6% gross margin, -12.6% operating margin). On trailing 12-month operating scale, SMCI generates $54.0B in USD-normalized revenue versus $276M for ZEPP. In operating R&D and SG&A reinvestment, SMCI deploys 3.1% of Rev ($1.67B) (0 90-day corporate R&D disclosures) versus 51.2% of Rev ($141M) (0 disclosures) for ZEPP.
ZEPP screens cheaper on headline valuation multiples. SMCI trades at 4.5x Forward P/E, 5.0x Trailing P/E, 0.91x PEG, and 0.3x EV/Revenue (-12.0% FCF margin), whereas ZEPP trades at 3.1x Forward P/E, 3.1x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-11.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SMCI (32.4% ROE) versus ZEPP (-21.2% ROE) capital efficiency.
In options market volatility and institutional positioning, SMCI carries 102.2% implied volatility (74th %ile, Elevated (60th–80th %ile)), a 1.35x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.70β · 85% Vol realized risk). By comparison, ZEPP carries 124.3% implied volatility (94th %ile, Extreme (>80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.12β · 68% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.